Boston Scientific Corp Stock Fundamentals
| BSX Stock | USD 67.44 0.63 0.93% |
Boston Scientific Corp fundamentals help investors to digest information that contributes to Boston Scientific's financial success or failures. It also enables traders to predict the movement of Boston Stock. The fundamental analysis module provides a way to measure Boston Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Boston Scientific stock.
At this time, Boston Scientific's Income Before Tax is fairly stable compared to the past year. Net Income is likely to rise to about 1.7 B in 2024, whereas Interest Expense is likely to drop slightly above 193.9 M in 2024. Boston | Select Account or Indicator |
Boston Scientific Corp Company Operating Margin Analysis
Boston Scientific's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Boston Scientific Operating Margin | 0.17 % |
Most of Boston Scientific's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Boston Scientific Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Boston Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Boston Scientific Corp has an Operating Margin of 0.1656%. This is 100.47% lower than that of the Health Care Equipment & Supplies sector and 100.42% lower than that of the Health Care industry. The operating margin for all United States stocks is 103.01% lower than that of the firm.
Boston Scientific Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Boston Scientific's current stock value. Our valuation model uses many indicators to compare Boston Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Boston Scientific competition to find correlations between indicators driving Boston Scientific's intrinsic value. More Info.Boston Scientific Corp is rated below average in return on equity category among related companies. It is rated third in return on asset category among related companies reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Boston Scientific Corp is roughly 1.92 . At this time, Boston Scientific's Return On Equity is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Boston Scientific by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Boston Scientific's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Boston Scientific's earnings, one of the primary drivers of an investment's value.Boston Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Boston Scientific's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Boston Scientific could also be used in its relative valuation, which is a method of valuing Boston Scientific by comparing valuation metrics of similar companies.Boston Scientific is currently under evaluation in operating margin category among related companies.
Boston Scientific ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Boston Scientific's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Boston Scientific's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Boston Fundamentals
| Return On Equity | 0.0858 | ||||
| Return On Asset | 0.0447 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 107.89 B | ||||
| Shares Outstanding | 1.47 B | ||||
| Shares Owned By Insiders | 0.19 % | ||||
| Shares Owned By Institutions | 93.65 % | ||||
| Number Of Shares Shorted | 12.43 M | ||||
| Price To Earning | 107.05 X | ||||
| Price To Book | 5.19 X | ||||
| Price To Sales | 7.03 X | ||||
| Revenue | 14.24 B | ||||
| Gross Profit | 8.68 B | ||||
| EBITDA | 3.62 B | ||||
| Net Income | 1.59 B | ||||
| Cash And Equivalents | 928 M | ||||
| Cash Per Share | 0.24 X | ||||
| Total Debt | 9.49 B | ||||
| Debt To Equity | 0.51 % | ||||
| Current Ratio | 1.45 X | ||||
| Book Value Per Share | 13.15 X | ||||
| Cash Flow From Operations | 2.5 B | ||||
| Short Ratio | 2.01 X | ||||
| Earnings Per Share | 1.07 X | ||||
| Price To Earnings To Growth | 1.80 X | ||||
| Target Price | 72.95 | ||||
| Number Of Employees | 48 K | ||||
| Beta | 0.79 | ||||
| Market Capitalization | 99.13 B | ||||
| Total Asset | 35.14 B | ||||
| Retained Earnings | 819 M | ||||
| Working Capital | 1.58 B | ||||
| Current Asset | 1.21 B | ||||
| Current Liabilities | 923 M | ||||
| Net Asset | 35.14 B |
About Boston Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Boston Scientific Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boston Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boston Scientific Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 266 M | 333.1 M | |
| Total Revenue | 14.2 B | 15 B | |
| Cost Of Revenue | 4.3 B | 4.6 B | |
| Stock Based Compensation To Revenue | 0.02 | 0.02 | |
| Sales General And Administrative To Revenue | 0.33 | 0.29 | |
| Research And Ddevelopement To Revenue | 0.1 | 0.13 | |
| Capex To Revenue | (0.06) | (0.06) | |
| Revenue Per Share | 9.80 | 10.29 | |
| Ebit Per Revenue | 0.16 | 0.10 |
Pair Trading with Boston Scientific
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boston Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Scientific will appreciate offsetting losses from the drop in the long position's value.Moving together with Boston Stock
| 0.74 | ENSG | Ensign Group Financial Report 24th of April 2024 | PairCorr |
Moving against Boston Stock
| 0.87 | XRAY | Dentsply Sirona Financial Report 1st of May 2024 | PairCorr |
| 0.85 | INNV | InnovAge Holding Corp Financial Report 14th of May 2024 | PairCorr |
| 0.74 | LUCY | Innovative Eyewear | PairCorr |
| 0.64 | MMSI | Merit Medical Systems Financial Report 24th of April 2024 | PairCorr |
| 0.63 | FIGS | Figs Inc Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Boston Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boston Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boston Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boston Scientific Corp to buy it.
The correlation of Boston Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boston Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boston Scientific Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Boston Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Boston Scientific Piotroski F Score and Boston Scientific Altman Z Score analysis. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Boston Stock analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.856 | Earnings Share 1.07 | Revenue Per Share 9.8 | Quarterly Revenue Growth 0.149 | Return On Assets 0.0447 |
The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.